GHCM
ITRM

Glen Harbor Capital Management’s Iterum Therapeutics ITRM Stock Holding History

Glen Harbor Capital Management’s Portfolio ITRM Stock Details ITRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		$112K Sell
1,264
-52
-4% -$5.06K ﹤0.01% 1151
2019
Q2 		$136K Sell
1,316
-246
-16% -$27.4K ﹤0.01% 1119
2019
Q1 		$188K Sell
1,562
-373
-19% -$34.2K ﹤0.01% 1006
2018
Q4 		$145K Hold
1,935
– – ﹤0.01% 1034
2018
Q3 		$195K Sell
1,935
-10
-0.5% -$1.31K ﹤0.01% 1059
2018
Q2 		$318K Buy
+1,945
New +$351K 0.01% 816

Other funds holding ITRM

SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
TAM
Tiverton Asset Management Wilimington, Delaware $2.88B AUM 5.6% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return
NA
Neuburgh Advisers Los Angeles, California $3.22B AUM 3.74% 1-Year Est. Return
FCM
Flinton Capital Management Philadelphia, Pennsylvania $3.22B AUM 4.75% 1-Year Est. Return

Glen Harbor Capital Management's ITRM Position: Q3 2019 in Review

Glen Harbor Capital Management reduced its Iterum Therapeutics (ITRM) stake by 4% in Q3 2019, selling an estimated $5.06K and leaving 1,264 shares worth $112K. The position accounts for ﹤0.01% of the portfolio, ranked #1151.

Glen Harbor Capital Management first reported a position in ITRM in Q2 2018 and has held it in 6 quarters since. The position peaked at $318K in Q2 2018. 19 funds tracked by Wall St. Rank hold ITRM as of Q3 2019.

  • Glen Harbor Capital Management held 1,264 shares of Iterum Therapeutics worth $112K as of Q3 2019.
  • Glen Harbor Capital Management sold 52 Iterum Therapeutics shares in Q3 2019, an estimated $5.06K.
  • Iterum Therapeutics made up ﹤0.01% of Glen Harbor Capital Management's portfolio in Q3 2019, its #1151 holding.
  • Glen Harbor Capital Management first reported a position in Iterum Therapeutics in Q2 2018 and has held it in 6 quarters since.
  • Glen Harbor Capital Management's Iterum Therapeutics position peaked at $318K in Q2 2018.
  • 19 funds tracked by Wall St. Rank held Iterum Therapeutics as of Q3 2019.

Based on Glen Harbor Capital Management's 13F filing for Q3 2019, filed 13 Nov 2019.